Caris Life Sciences, Inc.
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 148.8 | 47.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 13.8 | 13.9 | 9.6 | 5.6 | 5.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 16.3 | 18.8 | 13.6 | 8.5 | 8.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 13.2 | 13.3 | 9.1 | 5.1 | 4.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 651.0 | 41.5 | 27.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 117.0 | 41.0 | 34.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.9% | -0.2% | 0.9% | 2.4% | 2.9% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 66.4% | 66.1% | 65.7% | 65.3% | 64.6% | 62.5% | 50.5% | 48.7% | 46.4% | 41.5% | 46.7% | 44.3% | 43.4% | 46.1% | 48.6% | 49.9% | 50.3% | 50.1% | 49.4% | 49.3% | 49.0% | 48.8% | 48.3% | 48.1% | 50.8% | 54.0% | 57.8% | 58.3% | 69.0% | 66.1% | – | – | – | 43.4% | 46.3% | 53.5% | 59.9% | 66.4% | 68.7% | 69.7% | |
| 44.1% | 43.4% | 42.6% | 42.1% | 41.5% | 39.2% | 27.3% | 24.8% | 22.0% | 16.6% | 22.4% | 21.2% | 21.8% | 27.0% | 30.3% | 33.0% | 34.7% | 35.0% | 34.4% | 33.8% | 33.2% | 32.5% | 31.2% | 31.2% | 33.2% | 36.2% | 42.6% | 51.1% | 55.3% | 60.9% | – | – | – | -29.9% | -19.6% | -25.8% | -6.8% | 10.0% | 15.9% | 15.5% | |
| 26.9% | 26.7% | 26.5% | 25.7% | 25.0% | 22.9% | 10.7% | 7.9% | 4.2% | -2.5% | 2.0% | 1.3% | 4.1% | 10.9% | 20.7% | 23.2% | 23.8% | 23.3% | 18.2% | 17.9% | 15.4% | 9.7% | 7.3% | 2.7% | 0.3% | 5.9% | 8.6% | 21.6% | 33.4% | 41.9% | – | – | – | -68.4% | -60.4% | -52.3% | -28.8% | -8.4% | 3.7% | 10.6% | |
| -48.1% | -49.7% | -73.7% | -75.1% | -101.8% | -99.3% | -96.9% | -78.9% | -53.3% | -43.9% | -41.4% | -41.7% | -36.2% | -65.8% | -99.6% | -109.9% | -123.9% | -137.4% | -146.5% | -144.3% | -109.7% | -71.2% | -15.3% | 12.9% | 20.5% | 42.7% | 17.8% | -23.5% | -48.3% | -197.1% | – | – | – | -61.5% | -46.9% | -26.3% | -2.2% | 8.2% | 13.6% | 14.8% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| 13.8% | 14.0% | 13.6% | 13.0% | 12.5% | 11.7% | 5.8% | 4.4% | 2.4% | -1.5% | 1.3% | 0.9% | 2.7% | 7.2% | 12.8% | 13.5% | 14.6% | 13.7% | 11.2% | 11.4% | 10.0% | 6.2% | 4.5% | 1.6% | 0.2% | 3.1% | 3.9% | 8.9% | 13.7% | 17.4% | – | – | – | – | – | -61.6% | -39.1% | -11.8% | 5.7% | 17.8% | |
| 3.4% | 3.3% | 3.4% | 3.2% | 3.0% | 2.8% | 1.4% | 1.0% | 0.6% | -0.3% | 0.3% | 0.2% | 0.6% | 1.5% | 3.0% | 3.3% | 3.4% | 3.2% | 2.6% | 2.7% | 2.3% | 1.4% | 1.1% | 0.4% | 0.0% | 0.7% | 1.1% | 2.4% | 3.5% | 4.3% | – | – | – | -82.0% | -93.8% | -29.2% | -19.0% | -6.0% | 2.9% | 8.6% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 184 | 134 | 150 | 168 | 170 | 70 | 120 | 61 | 58 | 62 | 49 | 53 | 87 | 98 | 97 | 125 | 119 | 156 | 266 | 271 | 256 | 261 | 172 | 108 | 203 | 460 | 130 | 136 | 78 | 115 | – | – | – | 2.2 | 352 | -338 | -370 | -419 | -434 | -291 | |
| 1.1 | 0.7 | 0.8 | 0.9 | 0.9 | 0.4 | 0.7 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | 0.9 | 0.9 | 0.9 | 0.9 | 0.7 | 0.5 | 0.9 | 2.0 | 0.5 | 0.5 | 0.3 | 0.4 | – | – | – | – | – | – | – | -36.8 | -3.9 | -1.7 | |
| 24.2% | 23.8% | 24.6% | 24.4% | 24.1% | 23.8% | 23.2% | 23.2% | 22.9% | 22.6% | 22.3% | 22.5% | 22.7% | 21.2% | 23.2% | 24.4% | 23.1% | 23.2% | 23.3% | 24.1% | 23.2% | 23.2% | 23.9% | 24.0% | 25.0% | 22.8% | 26.9% | 27.1% | 25.6% | 24.5% | – | – | – | -80.6% | -891.6% | 47.4% | 48.6% | 51.3% | 51.1% | 48.1% | |
| 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.3 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.5 | 0.3 | 0.3 | 0.4 | 0.7 | 0.3 | 0.3 | 0.2 | 0.2 | – | – | – | – | – | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| 2.62 | 2.80 | 2.85 | 2.80 | 2.76 | 2.64 | 1.32 | 1.03 | 0.58 | -0.37 | 0.31 | 0.21 | 0.67 | 1.83 | 3.58 | 4.06 | 4.62 | 4.91 | 4.07 | 4.24 | 3.85 | 2.43 | 1.78 | 0.64 | 0.07 | 1.21 | 1.55 | 3.70 | 5.91 | 7.93 | – | – | – | -1.00 | -1.07 | -1.01 | -0.63 | -0.23 | 0.12 | 0.37 | |
| 9.75 | 10.47 | 10.76 | 10.89 | 11.02 | 11.53 | 12.32 | 13.02 | 13.90 | 14.78 | 15.43 | 16.06 | 16.48 | 16.89 | 17.29 | 17.52 | 19.42 | 21.06 | 22.39 | 23.73 | 24.98 | 25.10 | 24.35 | 24.00 | 22.07 | 20.33 | 18.06 | 17.12 | 17.73 | 18.92 | – | – | – | 1.47 | 1.78 | 1.93 | 2.18 | 2.80 | 3.21 | 3.50 | |
| 18.95 | 20.00 | 20.90 | 21.55 | 22.11 | 22.55 | 22.71 | 23.34 | 23.96 | 23.99 | 23.98 | 24.17 | 24.70 | 25.39 | 27.98 | 30.13 | 31.69 | 35.73 | 36.33 | 37.32 | 38.61 | 39.14 | 39.77 | 39.59 | 39.06 | 39.48 | 39.12 | 41.45 | 43.27 | 45.67 | -0.08 | – | – | -0.99 | -10.20 | 1.64 | 1.61 | 1.99 | 2.10 | 2.09 | |
| -4.69 | -5.21 | -7.93 | -8.18 | -11.22 | -11.45 | -11.94 | -10.27 | -7.41 | -6.48 | -6.39 | -6.69 | -5.96 | -11.12 | -17.22 | -19.26 | -24.05 | -28.93 | -32.81 | -34.26 | -27.41 | -17.86 | -3.74 | 3.10 | 4.52 | 8.69 | 3.21 | -4.03 | -8.57 | -37.28 | – | – | – | -0.90 | -0.83 | -0.51 | -0.05 | 0.23 | 0.44 | 0.52 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.